| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| mavrilimumab | granulocyte-macrophage colony-stimulating factor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
0.78 | phase 2 | unknown |
| mavrilimumab | gmcsfr-alpha | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
15.91 | phase 2 | unknown |
| mavrilimumab | gmcsfr-alpha | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
15.91 | phase 2 | antibody |
| click here to return to the previous page | ||||||||